Dapagliflozin and Cholesterol Metabolism in Type 2 Diabetes (DM2)
Clinical trial NCT03074630 · COMPLETED
Trial details
- NCT number
- NCT03074630
- Sponsor
- Amsterdam UMC, location VUmc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2018-04-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.